Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Central line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients: clinical outcome and management

4 Feb 2014

Abstract excerpt

BACKGROUND: There are limited data regarding clinical presentation and management of Staphylococcus aureus central line- associated bloodstream infection (CLABSI) in immunocompromised cancer patients. METHODS: In this review, we evaluated 299 patients with 304 episodes of S. aureus-CLABSI between 2005 and 2011. FINDINGS: By multivariate analysis, the major predictors of complicated S. aureus-CLABSI were septic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Neutropenia and Cancer Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24491173
DOI: 10.3109/07853890.2013.878513

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Central line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients: clinical outcome and managementPMID 24491173Read ↗

Predictors of central line-associated bloodstream infections in cancer patients undergoing chemotherapy through implanted venous access ports: a cross-sectional, observational studySemantic proximity Read ↗

Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid TumorsSemantic proximity Read ↗

Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, ChinaSemantic proximity Read ↗

Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.Semantic proximity Read ↗

Risk Factors and Clinical Characteristics of Catheter Line-associated Bloodstream Infection in MIMIC IV DatabaseSemantic proximity Read ↗

Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysisSemantic proximity Read ↗

Central line–associated bloodstream infections in the pediatric intensive care and hemato-oncology unit: a prospective observational study from Western IndiaSemantic proximity Read ↗

Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysisSemantic proximity Read ↗

Incidence and Economic Burden of Infections in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Cohort StudySemantic proximity Read ↗

A Formal Outpatient Parenteral Antimicrobial Therapy Program for Patients with Solid TumorsSemantic proximity Read ↗

Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization.Semantic proximity Read ↗

Changing Epidemiology of Infections in Patients with Neutropenia and Cancer: Emphasis on Gram-Positive and Resistant BacteriaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.